51
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum]

Pages 7055-7056 | Published online: 10 Sep 2021
This article refers to:
Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma

Shen Y, Xu H, Li L, et al. Cancer Manag Res. 2021;13:5725–5737.

The authors have advised due to an error at the time of figure assembly, the legend shown in was incorrectly written as AUC at 1 years, AUC at 2 years and AUC at 3 years, it should read AUC at 1 years, AUC at 3 years and AUC at 5 years, respectively.

The correct is shown below.

Figure 7 The establishment of a nomogram that can predict the 1-, 3-, and 5-year survival rates of patients with OSCC. (A) Cox proportional hazards regression analysis for PRDX1 and clinical features; (B) A nomogram containing Tumor stage, N stage and PRDX1 level; (C and D) The accuracy of nomogram in the TCGA cohort and testing cohort was verified by the ROC curve.

Figure 7 The establishment of a nomogram that can predict the 1-, 3-, and 5-year survival rates of patients with OSCC. (A) Cox proportional hazards regression analysis for PRDX1 and clinical features; (B) A nomogram containing Tumor stage, N stage and PRDX1 level; (C and D) The accuracy of nomogram in the TCGA cohort and testing cohort was verified by the ROC curve.

The authors apologize for this error and advise it does not affect the scientific conclusions of the paper.